Aliénor Estrade

Aliénor has recently represented: 

• Orange on a 50:50 joint venture with MasMovil, valued at €18.6 billion, to combine their Spanish businesses (EC Phase II clearance with remedies) 
• SK Capital in obtaining global antitrust clearance for its acquisition of Seqens 
• ArchiMed’s portfolio company, Natus Medical Incorporated, in obtaining FDI clearance for its acquisition of Micromed Holding SAS 
• Confidential foreign investors in obtaining FDI review approvals and negotiation conditions with relevant governmental authorities
• Global companies in a variety of sectors on the implementation of the EU Regulation on Foreign Subsidies (FSR)
• AkzoNobel in obtaining global antitrust clearance for its acquisition of Mapaero*
• TDF in its victory before the Paris Court of Appeal against a decision by the French Competition Authority refusing to revise remedies 
• A confidential client in the cartel investigation by the French Competition Authority into nuclear engineering services
• Amadeus, the #2 European software company, in its defence against an Article 102 complaint by Optionizr before the French Competition Authority, obtaining the dismissal of the request for interim measures*
• A television channel before the Paris commercial court in proceedings for alleged abuse of dominant position against a distributor*
• A pool of banks in relation to the Areva restructuring with respect to state aid law*

*Matter handled prior to joining Latham